Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Alimentary Pharmacology & Therapeutics|September 22, 2012
The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based studyA A N Syed, C N Andrews, E Shaffer, et al.
Neurogastroenterology and Motility|February 18, 2010
Cannabinoid 1 receptors modulate intestinal sensory and motor function in ratB Yüce, M Kemmer, G Qian, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 16, 2017
Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in miceM Salaga, H Zatorski, M Zielińska, et al.
Neurogastroenterology and Motility|August 1, 2015
The GPR55 antagonist CID16020046 protects against intestinal inflammationA Stančić, K Jandl, C Hasenöhrl, et al.
Zeitschrift Fur Gastroenterologie|September 15, 2009
[Performance and interpretation of esophageal manometry: recommendations of the German Societies for Neurogastroenterology and Motility (DGNM), for Digestive and Metabolic Diseases (DGVS) and for General and Visceral Surgery (DGAV)]J Keller, I van der Voort, C Pehl, et al.
Alimentary Pharmacology & Therapeutics|December 5, 2008
The role of fatty acid hydrolase gene variants in inflammatory bowel diseaseM Storr, D Emmerdinger, J Diegelmann, et al.
Endoscopy|July 29, 2004
Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease: multicenter study of the Gatekeeper Reflux Repair SystemP Fockens, M J Bruno, A Gabbrielli, et al.
Computer Methods and Programs in Biomedicine|September 7, 2013
Kinetic modelling of haemodialysis removal of myoglobin in rhabdomyolysis patientsR Keir, N D Evans, C A Hutchison, et al.
The International Journal of Artificial Organs|June 7, 2007
Beta2-microglobulin removal and plasma albumin levels with high cut-off hemodialysisM Haase, R Bellomo, I Baldwin, et al.
British Journal of Pharmacology|June 16, 2015
Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivityU Taschler, T O Eichmann, F P W Radner, et al.
Pageof 18